While prophylactic treatment is the standard treatment for severe hemophilia, its implementation can be complicated in ...

Although Medicare Advantage plan member satisfaction has dropped, areas for improvement have emerged in the form of digital ...

A new Business Group on Health survey finds that nearly a quarter of all employer healthcare spending (24%) went to pharmacy ...

An expert discusses how gene therapy represents a breakthrough treatment approach for BCG-unresponsive patients, offering ...

An expert discusses how patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) now have several ...

We’ll be back on Monday morning with more fresh content!

In this second part of a three-part of a video series, Kasey Raetz, Pharm.D., a PBMI Innovator, told MHE about leading the ...

In this final video of a three-part video series, Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and a ...

Developed by Ionis Pharmaceuticals, Dawnzera is the first RNA-targeted medicine approved for HAE, designed to target plasma ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The next step for the Rise For Health study researchers is to study the health benefits of frequent standing in older men and ...

Sexual and gender minority individuals still face insurance denials and cost-sharing barriers when accessing pre-exposure ...